Navigation Links
Diabetes Drug Actos Caused Bladder Cancer and Wrongful Death of Ohio Man, Alleges Lawsuit Filed by Parker Waichman LLP
Date:5/14/2013

New York, New York (PRWEB) May 14, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit on behalf of the estate of an Ohio man who developed bladder cancer and subsequently died, allegedly from using Actos. The suit was filed on April 2, 2013, in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-0706), where it is one of thousands of cases pending in the Actos multidistrict litigation (In Re: Actos (Pioglitazone) Products Liability Litigation, MDL No. 6:11-md-2299). Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiffs’ Steering Committee in the litigation. Takeda Pharmaceuticals, America; Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc.; Takeda Pharmaceutical Company Limited; and Eli Lilly and Company have been named as Defendants.

According to the Complaint, the Plaintiff’s decedent took Actos from June 2002 to February 2007, at about which time he stopped taking the drug and had developed bladder cancer. He died in September 2007 of the bladder cancer, which was allegedly caused by Actos. The Defendants were allegedly aware that taking the diabetes drug could lead to an increased risk of bladder cancer, but failed to disclose this information to the Plaintiff, his doctor and other consumers. The suit seeks damages for extensive pain and suffering, severe emotional distress. Actos’ side effects greatly reduced the Decedent’s ability to enjoy life, the suit alleges.

Actos is a Type 2 diabetes medication that was approved by the U.S. Food and Drug Administration in 1999. In 2011, the agency updated the label to warn that users may face an increased risk of bladder cancer after taking the drug for only one year. (http://www.fda.gov/Drugs/DrugSafety/ucm266555.htm)

Studies have continued to suggest that Actos can increase the risk of bladder cancer. For instance, the May 31, 2012 issue of the British Medical Journal* found that Actos users were twice as likely to develop bladder cancer after two years. In July 3, 2012, the Canadian Medical Association Journal** found that patients taking the medication were 22 percent more likely to get bladder cancer.

Parker Waichman LLP continues to offer free legal consultations to victims of Actos injuries, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
http://www.yourlawyer.com

*http://www.bmj.com/content/344/bmj.e3645
**http://www.cmaj.ca/content/early/2012/07/03/cmaj.112102

Read the full story at http://www.prweb.com/releases/actos-attorneys/052013/prweb10732524.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. PreDiabetes Centers Welcomes Concierge Chef to the Nutrition Team
2. Popular diabetes drug does not improve survival rates after cancer: Study
3. Positive social support at work shown to reduce risk of diabetes
4. PreDiabetes Centers Welcomes Diabetes Guest Blogger to The PreD Blog
5. Dr. Meg Qayum Leads Prediabetes Treatment Center in Houston
6. Faculty List for Continuing Medical Education (CME) Conference 17th Annual Conference on Hypertension, Diabetes and Dyslipidemia Released by Continuing Education Company
7. New mouse model confirms how type 2 diabetes develops
8. DrugRisk Adds New Pancreatic Cancer Warning for Diabetes Drug Januvia
9. Gastric bypass findings could lead to diabetes treatment
10. How Weight-Loss Surgery Improves Diabetes Control
11. Mileageads Ad Network Now Invites Bloggers and Businesses in the Diabetes Niche to Join their Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... 09, 2016 , ... United Methodist Communications collaborated with Chocolate ... animated video designed to prevent the next widespread Ebola outbreak from ... being distributed throughout Togo, Liberia, Sierra Leone, Nigeria, Côte d’Ivoire and other African ...
(Date:2/9/2016)... ... February 09, 2016 , ... i2i Systems, an early innovator and developer ... vendors in the latest KLAS report, Population Health Management 2015: How Far Can Your ... for population health management (PHM). The latest KLAS Report, leveraging over 200 user ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Brain Preservation Foundation’s ... team from 21st Century Medicine (21CM) ( http://www.21cm.com/ ), spearheaded by recent ... circuits of an intact rabbit brain for extremely long-term storage using a combination ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... launched its newly redesigned website, federallabs.org . The site houses a wealth ... license available federal technologies through the process called technology transfer (T2). As a ...
(Date:2/8/2016)... ... February 08, 2016 , ... Coast Dental has a new way to help ... Month and family dentist Yvonne Dorrian, DMD, is hosting a free seminar on Friday, ... next to Target at 1207 North Peachtree Parkway in Peachtree City. Dr. Dorrian will ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... , Feb. 9, 2016  Increasingly, health care professionals ... vital signs with wireless technology. With the Vios Monitoring ... patient oversight and remotely detect problems before they become ... across in-hospital environments. the United States ... States . --> The Vios ...
(Date:2/9/2016)... , Feb. 9, 2016  Johnson & Johnson (NYSE: ... Markets Global Healthcare Conference on Tuesday, Feb. 23, at ... Dominic Caruso , Vice President, Finance & Chief Financial ... will represent the Company in a session scheduled at ... --> www.investor.jnj.com . --> This ...
(Date:2/9/2016)... and HONG KONG , Feb. 9, 2016 ... , PhD, has joined Athenex as Vice President of Corporate ... Raymond Yeung , MSc, MBA has joined as Senior Director ... Hong Kong . Simon Pedder ... that I have known for a while. Coupled together with ...
Breaking Medicine Technology: